ADMP Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 1.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Adamis Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Adamis Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adamis Pharmaceuticals Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 09/7/2023 04:59 PM ET

This chart shows the closing price history over time for ADMP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Adamis Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2022David C BenedictoCFOSell51$42.70$2,177.70View SEC Filing Icon  
3/18/2022David J MarguglioSVPSell169$42.00$7,098.00View SEC Filing Icon  
3/18/2022Dennis J Phd CarloCEOSell149$42.00$6,258.00View SEC Filing Icon  
3/18/2022Ronald B MossInsiderSell117$42.00$4,914.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Adamis Pharmaceuticals (NASDAQ:ADMP)

38.55% of Adamis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADMP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adamis Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/2/2022Verdence Capital Advisors LLC58,382$33K0.0%-59.3%0.039%Search for SEC Filing on Google Icon
4/25/2022Capital CS Group LLC70,513$40K0.0%N/A0.047%Search for SEC Filing on Google Icon
1/24/2022Avantax Advisory Services Inc.54,000$33K0.0%+68.8%0.036%Search for SEC Filing on Google Icon
11/15/2021Atom Investors LP56,492$55K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,333,913$1.29M0.0%+3.7%0.896%Search for SEC Filing on Google Icon
8/17/2021Balyasny Asset Management LLC1,622,510$1.79M0.0%N/A1.090%Search for SEC Filing on Google Icon
8/16/2021Squarepoint Ops LLC114,188$0.13M0.0%+785.6%0.077%Search for SEC Filing on Google Icon
8/16/2021Greenlight Capital Inc.1,000,000$1.10M0.1%N/A0.672%Search for SEC Filing on Google Icon
8/16/2021State Street Corp420,205$0.46M0.0%+835.9%0.282%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.241,991$0.27M0.0%N/A0.163%Search for SEC Filing on Google Icon
8/13/2021Natixis38,600$42K0.0%N/A0.026%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC1,286,139$1.41M0.0%+19.4%0.864%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.6,313,841$6.95M0.0%+10.2%4.241%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.42,900$47K0.0%+261.6%0.029%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp84,002$92K0.0%N/A0.056%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.2,742,498$3.02M0.0%+45.2%1.842%Search for SEC Filing on Google Icon
8/10/2021Principal Financial Group Inc.32,384$36K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/6/2021Verdence Capital Advisors LLC143,382$0.16M0.0%+145.6%0.096%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC346,296$0.33M0.0%N/A0.233%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC414,540$0.39M0.0%N/A0.278%Search for SEC Filing on Google Icon
5/17/2021Edmond DE Rothschild Holding S.A.100,000$94K0.0%N/A0.067%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp40,000$38K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC31,654$30K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC822,655$0.77M0.0%N/A0.553%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp258,851$0.24M0.0%+50.5%0.174%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,076,975$1.01M0.0%+92.9%0.723%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG50,000$47K0.0%-27.3%0.034%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,888,314$1.78M0.0%+41.6%1.268%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP271,626$0.13M0.0%-9.7%0.202%Search for SEC Filing on Google Icon
2/12/2021Verdence Capital Advisors LLC58,382$28K0.0%-33.9%0.065%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP516,203$0.25M0.0%+825.9%0.573%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC39,683$31K0.0%N/A0.044%Search for SEC Filing on Google Icon
11/9/2020Verdence Capital Advisors LLC88,382$69K0.0%N/A0.098%Search for SEC Filing on Google Icon
11/6/2020GSA Capital Partners LLP55,752$44K0.0%N/A0.062%Search for SEC Filing on Google Icon
11/2/2020Level Four Advisory Services LLC32,000$25K0.0%-40.2%0.036%Search for SEC Filing on Google Icon
10/29/2020Cambridge Investment Research Advisors Inc.46,849$37K0.0%N/A0.052%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG61,575$33K0.0%+426.3%0.083%Search for SEC Filing on Google Icon
5/15/2020Sabby Management LLC88,210$32K0.0%N/A0.121%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC629,742$0.44M0.0%+86.8%1.022%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.
Read More on Adamis Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: $1.28
Low: $0.77
High: $3.99

52 Week Range

Now: N/A

Volume

119,800 shs

Average Volume

811,695 shs

Market Capitalization

$7.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27